AAAAAA
Results:
1-14
|
Results: 14
Authors:
Borghouts, LB
Schrauwen, P
Blaak, EE
Wagenmakers, AJM
Citation: Lb. Borghouts et al., Differences in acetate recovery factor between groups may interfere with tracer estimates of fat oxidation, J APP PHYSL, 90(6), 2001, pp. 2520-2521
Authors:
Schiffelers, SLH
Blaak, EE
Baarends, EM
Van Baak, MA
Saris, WHM
Wouters, EFM
Schols, AMWJ
Citation: Slh. Schiffelers et al., beta-Adrenoceptor-mediated thermogenesis and lipolysis in patients with chronic obstructive pulmonary disease, AM J P-ENDO, 280(2), 2001, pp. E357-E364
Authors:
Blaak, EE
Wolffenbuttel, BHR
Saris, WHM
Pelsers, MMAL
Wagenmakers, AJM
Citation: Ee. Blaak et al., Weight reduction and the impaired plasma-derived free fatty acid oxidationin type 2 diabetic subjects, J CLIN END, 86(4), 2001, pp. 1638-1644
Authors:
Blaak, EE
Glatz, JFC
Saris, WHM
Citation: Ee. Blaak et al., Increase in skeletal muscle fatty acid binding protein (FABPC) content is directly related to weight loss and to changes in fat oxidation following avery low calorie diet, DIABETOLOG, 44(11), 2001, pp. 2013-2017
Authors:
Mensink, M
Blaak, EE
van Baak, MA
Wagenmakers, AJM
Saris, WHM
Citation: M. Mensink et al., Plasma free fatty acid uptake and oxidation are already diminished in subjects at high risk for developing type 2 diabetes, DIABETES, 50(11), 2001, pp. 2548-2554
Authors:
Blaak, EE
Citation: Ee. Blaak, Adrenergically stimulated fat utilization and ageing, ANN MED, 32(6), 2000, pp. 380-382
Authors:
Blaak, EE
Wagenmakers, AJM
Glatz, JFC
Wolffenbuttel, BHR
Kemerink, GJ
Langenberg, CJM
Heidendal, GAK
Saris, WHM
Citation: Ee. Blaak et al., Plasma FFA utilization and fatty acid-binding protein content are diminished in type 2 diabetic muscle, AM J P-ENDO, 279(1), 2000, pp. E146-E154
Authors:
Schrauwen, P
Blaak, EE
van Aggel-Leijssen, DPC
Borghouts, LB
Wagenmakers, AJM
Citation: P. Schrauwen et al., Determinants of the acetate recovery factor: implications for estimation of [C-13]substrate oxidation, CLIN SCI, 98(5), 2000, pp. 587-592
Authors:
Schrauwen, P
Schaart, G
Saris, WHM
Slieker, LJ
Glatz, JFC
Vidal, H
Blaak, EE
Citation: P. Schrauwen et al., The effect of weight reduction on skeletal muscle UCP2 and UCP3 mRNA expression and UCP3 protein content in Type II diabetic subjects, DIABETOLOG, 43(11), 2000, pp. 1408-1416
Authors:
Blaak, EE
van Aggel-Leijssen, DPC
Wagenmakers, AJM
Saris, WHM
van Baak, MA
Citation: Ee. Blaak et al., Impaired oxidation of plasma-derived fatty acids in type 2 diabetic subjects during moderate-intensity exercise, DIABETES, 49(12), 2000, pp. 2102-2107
Authors:
Schiffelers, SLH
Blaak, EE
Saris, WHM
van Baak, MA
Citation: Slh. Schiffelers et al., In vivo beta(3)-adrenergic stimulation of human thermogenesis and lipid use, CLIN PHARM, 67(5), 2000, pp. 558-566
Authors:
Blaak, EE
Saris, WHM
Wolffenbuttel, BHR
Citation: Ee. Blaak et al., Substrate utilization and thermogenic responses to beta-adrenergic stimulation in obese subjects with NIDDM, INT J OBES, 23(4), 1999, pp. 411-418
Authors:
Blaak, EE
Kemerink, GJ
Pakbiers, MTW
Wolffenbuttel, BHR
Heidendal, GA
Saris, WHM
Citation: Ee. Blaak et al., Microdialysis assessment of local adipose tissue lipolysis during beta-adrenergic stimulation in upper-body-obese subjects with type II diabetes, CLIN SCI, 97(4), 1999, pp. 421-428
beta-adrenergically stimulated fat oxidation is diminished in middle-aged compared to young subjects
Authors:
Blaak, EE
van Baak, MA
Saris, WHM
Citation: Ee. Blaak et al., beta-adrenergically stimulated fat oxidation is diminished in middle-aged compared to young subjects, J CLIN END, 84(10), 1999, pp. 3764-3769
Risultati:
1-14
|